new_0222_0469|RXDX|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0469|RXDX|1|Prometheus Biosciences Inc Total Current Assets (Quarterly) (USD)|Prometheus Biosciences Inc Cash and Short Term Investments (Quarterly) (USD)|Prometheus Biosciences Inc Inventories (Quarterly) (USD)|Prometheus Biosciences Inc Net PP&E (Quarterly) (USD)|Prometheus Biosciences Inc Goodwill and Intangibles (Quarterly) (USD)|Prometheus Biosciences Inc Total Liabilities (Quarterly) (USD)|Prometheus Biosciences Inc Total Current Liabilities (Quarterly) (USD)|Prometheus Biosciences Inc Total Long Term Liabilities (Quarterly) (USD)|Prometheus Biosciences Inc Total Deposits (Quarterly) (USD)|Prometheus Biosciences Inc Book Value (Quarterly) (USD)|Prometheus Biosciences Inc Retained Earnings (Quarterly) (USD)|Prometheus Biosciences Inc Treasury Stock (Quarterly) (USD)|Prometheus Biosciences Inc EV to Revenues|Prometheus Biosciences Inc EV to Earnings|Prometheus Biosciences Inc EV to Free Cash Flow|Prometheus Biosciences Inc EV to Assets (Quarterly)|Prometheus Biosciences Inc PS Ratio|Prometheus Biosciences Inc PE Ratio|Prometheus Biosciences Inc Price to Book Value|Prometheus Biosciences Inc PEG Ratio|Prometheus Biosciences Inc Debt to Equity Ratio|Prometheus Biosciences Inc Dividend Yield|Prometheus Biosciences Inc Shareholder Yield (TTM)|Prometheus Biosciences Inc Percent of Shares Outstanding Short|Prometheus Biosciences Inc Total Receivables (Quarterly) (USD)|Prometheus Biosciences Inc Total Payables (Quarterly) (USD)|Prometheus Biosciences Inc Total Capital Stock (Quarterly) (USD)|Prometheus Biosciences Inc Return on Invested Capital|Prometheus Biosciences Inc Quality Ratio Score|Prometheus Biosciences Inc Momentum Score|Prometheus Biosciences Inc Beta (1Y)|Prometheus Biosciences Inc Sustainable Growth Rate (TTM)|Prometheus Biosciences Inc Institutional Investor Ownership Percentage|Prometheus Biosciences Inc Average Diluted Shares Outstanding (Quarterly)|Prometheus Biosciences Inc Total Employees (Annual)|Prometheus Biosciences Inc EPS Diluted (Quarterly) (USD)|Prometheus Biosciences Inc Shares Outstanding|Prometheus Biosciences Inc Repurchase of Capital Stock (Quarterly) (USD)|Prometheus Biosciences Inc Ordinary Shares Number (Quarterly)|Prometheus Biosciences Inc Payout Ratio|Prometheus Biosciences Inc Quick Ratio (Quarterly)|Prometheus Biosciences Inc Normalized Diluted EPS (Quarterly) (USD)|Prometheus Biosciences Inc Stock Buybacks (Quarterly) (USD)|Prometheus Biosciences Inc Effective Tax Rate (TTM)|Prometheus Biosciences Inc Return on Equity|Prometheus Biosciences Inc Net Income (TTM) (USD)|Prometheus Biosciences Inc Revenue (TTM) (USD)|Prometheus Biosciences Inc Dividend Per Share (Quarterly) (USD)|Prometheus Biosciences Inc Revenue (Quarterly) (USD)|Prometheus Biosciences Inc Gross Profit (Quarterly) (USD)|Prometheus Biosciences Inc SG&A Expense (Quarterly) (USD)|Prometheus Biosciences Inc Pre-Tax Income (Quarterly) (USD)|Prometheus Biosciences Inc Net Income (Quarterly) (USD)|Prometheus Biosciences Inc Net Interest Income (Quarterly) (USD)|Prometheus Biosciences Inc Price (USD)|Prometheus Biosciences Inc Total Return Price (USD)|Prometheus Biosciences Inc Enterprise Value (USD)|Prometheus Biosciences Inc 30-Day Average Daily Volume|Prometheus Biosciences Inc 1 Year Price Returns (Daily)||
new_0222_0469|RXDX|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0469|RXDX|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|daily|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0469|RXDX|5|91.25|91.25||91.25||91.25|91.25|91.25||91.25|91.25||1.44357976654|91.6666666667|1.44357976654|91.6666666667|1.44357976654||1.44262295082|1.45283018868|91.25|1.44357976654|91.6666666667|15.2173913043|91.25|91.25|91.25|92||||92|30.3636363636|91.4285714286|152.5|91.4285714286|35.8||91.25|91.25|91.25|91.4285714286|91.4285714286||92|91.25|91.25||91.4285714286||91.4285714286|91.4285714286|91.4285714286|91.4285714286|1.44357976654|1.44357976654|1.44357976654|1.44298245614|1||
new_0222_0469|RXDX|6|4|4||4||4|4|4||4|4||257|3|257|3|257||244|53|4|257|3|23|4|4|4|2||||2|11|7|2|7|10||4|4|4|7|7||2|4|4||7||7|7|7|7|257|257|257|228|4||
new_0222_0469|RXDX|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0469|RXDX|202003||||||||||||||||||||||||||||||||||26.9849||-0.4865||||||-0.2578|||||||0.228||2.387|-6.954|-13.128|-0.532|||||||
new_0222_0469|RXDX|202006||||||||||||||||||||||||||||||||||26.9849||-0.3128||||||-0.2648|||||||0.179||1.81|-7.151|-8.44|-0.592|||||||
new_0222_0469|RXDX|202009||||||||||||||||||||||||||||||||||26.9849||-0.2574||||||-0.2901|||||||0.359||3.173|-7.826|-6.947|-0.361|||||||
new_0222_0469|RXDX|202012|57.456|54.201||0.447||157.174|15.255|141.919||-97.541|-99.146||||||||||-0.0759||||1.086|7.763||||||||34.6073||-0.2492|||34.6073||3.6242|-0.2657||||-37.138|1.229||0.463||3.719|-9.208|-8.623|-0.632|||||||
new_0222_0469|RXDX|202103|318.62|311.231||0.913||19.802|8.787|11.015||300.199|-113.091||229.4541|-10.646|-9.6015|1.2627|251.2332||2.3582||0.0245||-31.0202|0.71|0.973|2.315|0.004||||||92.1323|8.3389|36|-1.67|38.7697||38.7697||35.5302|-1.6574|-218.5|||-37.955|1.761||0.76||5.222|-13.945|-13.945|-0.64|18.26|18.26|404.0687|138631.3||24.57|23.29
new_0222_0469|RXDX|202106|311.589|304.389||1.109||30.738|17.698|13.04||282.428|-132.09||344.2333|-13.5383|-18.8702|2.0973|349.9445||3.3771||0.0262||-23.0637|1.9098|0.217|2.483|0.004|-28.6926||||-30.0033||38.8139||-0.49|38.8351||38.8351||17.2113|-0.49|||-30.0033|-48.514|1.908||0.326||5.618|-18.999|-18.999|-0.153|24.56|24.56|656.7971|221471.3667||20.97|21.82
new_0222_0469|RXDX|202109|287.108|279.116||1.362||26.838|15.093|11.745||262.1|-159.423||251.599|-9.33|-13.5135|2.2248|279.8069||3.5176||||-23.6997|3.0037|0.679|2.138|0.004|-35.8226||||-36.8851|89.562|38.8484||-0.7|38.8845||38.8845||18.5381|-0.6857|||-36.8851|-68.9|2.555||1.006||10.248|-27.333|-27.333|0.014|23.71|23.71|642.8355|76227.5333||31.86|29.7
new_0222_0469|RXDX|202112|265.383|257.254||1.447||32.646|16.442|16.204||235.155|-189.341||409.8933|-14.2198|-19.8412|4.7892|394.8988||6.5481|-0.0612|||-14.1901|4.0657|1.079|1.346|0.004|-44.8954||||-45.9082|92.7523|39.0002|72|-0.77|38.9431||38.9431||15.7118|-0.77|||-45.9082|-90.195|3.129||1.037||7.417|-29.918|-29.918|0.026|39.54|39.54|1282.5562|353019.5667||35.93|43.54
new_0222_0469|RXDX|202203|||||||||||||491.4658||-23.7898||458.8176||7.6335|-0.0711|||||||||||||||||39.0738||||||||||||||||||45.94|45.94|1537.7964|301031.1667|117.416||